Back to SC SCS Capital Management LLC

ALNYALNY
6 quarters

Position history for SCSCS Capital Management LLC's holdings in ALNYLAM PHARMACEUTICALS INC

Yes. SCS Capital Management holds 115,549 shares of ALNY (Alnylam Pharmaceuticals), worth $34.8M, as of its Q2 2026 13F filing. It reduced the position by 33,998 shares (-22.7%) from Q1 2026. SCS Capital Management has held ALNY since Q1 2025, across 6 quarterly 13F filings. ALNY is 0.3% of SCS Capital Management's reported 13F portfolio.

Current Value

$34.8M

Current Shares

115,549

Total Value Change

-$11.4M

Total Shares Change

-55,528

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
115,549
-22.7%
$34.8M0.3%$301.03
0
2026-Q1
Decreased
149,547
-0.0%
$49.5M0.5%$330.87
0
2025-Q4
Decreased
149,611
-0.7%
$59.5M0.6%$397.65
0
2025-Q3
Decreased
150,668
-11.7%
$68.7M0.7%$456.00
0
2025-Q2
Decreased
170,662
-0.2%
$55.7M0.6%$326.09
0
2025-Q1
New
171,077
-
$46.2M0.6%$270.02
57

Other major holders of ALNY: FMR LLC, Capital World Investors, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used